Bank of Montreal’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-100
Closed -$12K – 3979
2023
Q2
$12K Sell
100
-32
-24% -$3.19K ﹤0.01% 3789
2023
Q1
$13.5K Buy
+132
New +$20.2K ﹤0.01% 3584
2021
Q2
– Sell
-27
Closed -$20K – 4176
2021
Q1
$20K Sell
27
-88
-77% -$71K ﹤0.01% 4062
2020
Q4
$99K Buy
115
+77
+203% +$60.7K ﹤0.01% 3590
2020
Q3
$38K Sell
38
-17
-31% -$18K ﹤0.01% 3552
2020
Q2
$57K Buy
55
+50
+1,000% +$50.3K ﹤0.01% 3382
2020
Q1
$4K Sell
5
-70
-93% -$73.1K ﹤0.01% 3717
2019
Q4
$93K Buy
75
+17
+29% +$27.4K ﹤0.01% 3532
2019
Q3
$78K Buy
58
+23
+66% +$36.6K ﹤0.01% 3411
2019
Q2
$63K Buy
35
+20
+133% +$30.6K ﹤0.01% 3578
2019
Q1
$25K Buy
+15
New +$25K ﹤0.01% 3588

Other funds holding GOSS

Bank of Montreal's GOSS Position: Q3 2023 in Review

Bank of Montreal sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 100 shares — an estimated $12K sold.

Bank of Montreal first reported a position in GOSS in Q1 2019 and held it in 11 quarters. The position peaked at $99K in Q4 2020. 94 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Bank of Montreal reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 100 Gossamer Bio shares in Q3 2023, an estimated $12K.
  • Bank of Montreal first reported a position in Gossamer Bio in Q1 2019 and held it in 11 quarters.
  • Bank of Montreal's Gossamer Bio position peaked at $99K in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.